These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27123857)

  • 21. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
    Montravers P; Perrigault PF; Timsit JF; Mira JP; Lortholary O; Leroy O; Gangneux JP; Guillemot D; Bensoussan C; Bailly S; Azoulay E; Constantin JM; Dupont H;
    Clin Microbiol Infect; 2017 Feb; 23(2):117.e1-117.e8. PubMed ID: 27746395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole].
    Yamagishi Y; Terada M; Ohki E; Mikamo H
    Jpn J Antibiot; 2009 Oct; 62(5):415-34. PubMed ID: 20055119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model.
    Zhao Y; Prideaux B; Nagasaki Y; Lee MH; Chen PY; Blanc L; Ho H; Clancy CJ; Nguyen MH; Dartois V; Perlin DS
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
    Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
    Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    J Med Vet Mycol; 1995; 33(2):131-6. PubMed ID: 7658305
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Emami S; Lew SQ
    Perit Dial Int; 2018; 38(5):391-392. PubMed ID: 30185486
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?].
    Zaragoza R; Pemán J; Salavert M
    Rev Iberoam Micol; 2008 Dec; 25(4):203-7. PubMed ID: 19071886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?
    Dupont H; Guilbart M; Ntouba A; Perquin M; Petiot S; Regimbeau JM; Chouaki T; Mahjoub Y; Zogheib E
    Crit Care; 2015 Feb; 19(1):60. PubMed ID: 25849844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal infection with multiple species of Candida: a case report.
    Islam S; Zaidi AK; Wilson J
    Surg Infect (Larchmt); 2002; 3(1):35-7. PubMed ID: 12593698
    [No Abstract]   [Full Text] [Related]  

  • 30. Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain.
    Lagunes L; Rey-Pérez A; Martín-Gómez MT; Vena A; de Egea V; Muñoz P; Bouza E; Díaz-Martín A; Palacios-García I; Garnacho-Montero J; Campins M; Bassetti M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):95-104. PubMed ID: 27649699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors and outcomes associated with candidemia caused by non-albicans Candida spp versus Candida albicans in children.
    Lee WJ; Hsu JF; Lai MY; Chiang MC; Lin HC; Huang HR; Wu IH; Chu SM; Fu RH; Tsai MH
    Am J Infect Control; 2018 Dec; 46(12):1387-1393. PubMed ID: 30100260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Candida peritonitis in a haemodynamically stable patient. First choice of antifungal treatment … fluconazole?].
    Maseda E; Gilsanz F
    Rev Iberoam Micol; 2012; 29(2):81-4. PubMed ID: 22463782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of Candida glabrata peritonitis with fluconazole plus flucytosine in a premature infant following in vitro fertilization.
    Freydiere AM; Piens MA; Andre JM; Putet G; Picot S
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):704-5. PubMed ID: 16261301
    [No Abstract]   [Full Text] [Related]  

  • 34. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
    Li WS; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):370-376. PubMed ID: 26321461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
    Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
    BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    J Med Vet Mycol; 1995; 33(1):49-52. PubMed ID: 7650578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ravuconazole, a new triazole antifungal, in a rat intraabdominal abscess model.
    Mikamo H; Yin XH; Hayasaki Y; Satoh M; Tamaya T
    Chemotherapy; 2001; 47(5):377-80. PubMed ID: 11561141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    Rogiers O; Holtappels M; Siala W; Lamkanfi M; Van Bambeke F; Lagrou K; Van Dijck P; Kucharíková S
    J Antimicrob Chemother; 2018 Oct; 73(10):2806-2814. PubMed ID: 30010876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.